umu.sePublications
Change search
ReferencesLink to record
Permanent link

Direct link
Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population
Show others and affiliations
2016 (English)In: Cancer Prevention Research, ISSN 1940-6207, E-ISSN 1940-6215, Vol. 9, no 9, 758-765 p.Article in journal (Refereed) Published
Abstract [en]

We previously identified osteopontin (OPN) as a promising marker for the early detection of hepatocellular carcinoma (HCC). In this study, we investigated the association between prediagnostic circulating OPN levels and HCC incidence in a large population-based cohort. A nested case-control study was conducted within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. During a mean follow-up of 4.8 years, 100 HCC cases were identified. Each case was matched to two controls and OPN levels were measured in baseline plasma samples. Viral hepatitis, liver function, and a-fetoprotein (AFP) tests were also conducted. Conditional logistic regression models were used to calculate multivariable odds ratio (OR) and 95% confidence intervals (95% CI) for OPN levels in relation to HCC. Receiver operating characteristics curves were constructed to determine the discriminatory accuracy of OPN alone or in combination with other liver biomarkers in the prediction of HCC. OPN levels were positively associated with HCC risk (per 10% increment, ORmultivariable = 1.30; 95% CI, 1.14-1.48). The association was stronger among cases diagnosed within 2 years of follow-up. Adding liver function tests to OPN improved the discriminatory performance for subjects who developed HCC (AUC = 0.86). For cases diagnosed within 2 years, the combination of OPN and AFP was best able to predict HCC risk (AUC = 0.88). The best predictive model for HCC in this low-risk population is OPN in combination with liver function tests. Within 2 years of diagnosis, the combination of OPN and AFP best predicted HCC development, suggesting that measuring OPN and AFP could identify high-risk groups independently of a liver disease diagnosis.

Place, publisher, year, edition, pages
2016. Vol. 9, no 9, 758-765 p.
National Category
Surgery
Identifiers
URN: urn:nbn:se:umu:diva-126502DOI: 10.1158/1940-6207.CAPR-15-0434ISI: 000383090500006PubMedID: 27339170OAI: oai:DiVA.org:umu-126502DiVA: diva2:1040448
Available from: 2016-10-27 Created: 2016-10-10 Last updated: 2016-10-27Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Weiderpass, ElisabeteWerner, MårtenHemmingsson, Oskar
By organisation
Department of Public Health and Clinical MedicineDepartment of Surgical and Perioperative Sciences
In the same journal
Cancer Prevention Research
Surgery

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

ReferencesLink to record
Permanent link

Direct link